LBC PAP

Liquid-based Cytology (LBC) Pap test is a modernized technique for the screening of cervical cancer that is far better than conventional pap smear as it utilizes liquid medium to protect cell samples.

This test entails the collection of cervical cells which are placed in a liquid medium before being processed. This technique aids in better and clearer cervical cell screening since obscuring materials like mucus, blood, or other materials are removed, reducing unsatisfactory results.

The LBC test analyses the presence as well as type of abnormal changes of the cervical cells to identify pre-cancerous changes to other infections that might be present. The focal point of the screening is to check for abnormalities that will respond better to treatment.

The cytology Pap LBC test is performed in conjunction with regular cervical cancer screening. It is often recommended that women are screened for cervical cancer starting from the age of 21. The frequency of screening depends on guidelines, which vary, but typically every 3 years or more often if related tests are abnormal.

One of the advantages of the LBC pap test is that the risks involved with it are almost non-existent. While efficiently taking the sample, some patients experience mild morbid sensations. In some cases, the patients may have minor spotting after the test.

Limitations include the risk of having an abnormal result (false negative) when there is an abnormality, but none is detected. The accuracy always rights lie heavily on the methodology of sample collection and laboratory techniques employed during its processing.

These parameters include:

• The shape and size of cells, their arrangement as well as changes suggestive of the presence of an infection with an HPV or pre-cancerous changes to the cells.
• The patients’ medical history, age, and other related previous cervical disease.

This test is suitable for women over the age of 21 as part of their normal health check-ups. It is especially important to those who have a history of cervical disease and those with low immunity.

The lives of many women can be saved through early detection of cell abnormalities since preventative measures can be taken to avert cervical cancer. The LBC Pap test is more efficient since it collects adequate volume in one sample.

• Cervical intraepithelial neoplasia CIN
• Changes due to Human Papillomavirus HPV
• Early-stage cervical cancer
• Cancerous conditions such as infections that are not cancerous

Prerequisites: Intercourse, douching, and other vaginal products should be avoided 48 hours prior to the test.

Eligibility: In general, this is encouraged for women between 21-35 and comes with age-based frequency and previous results severity recommendations.

Procedure of Taking the Test: A speculum is put in to access the cervix when performing the procedure, and the healthcare worker uses the brush or a spatula to extract the cell sample.

Caution Before the Test: Plan your appointment for a time when you are not on your period for an optimal sample.